Multiple sclerosis (MS) is the most common neurological disorder among young adults. It is an auto-immune disease in which the body attacks its own tissues. The immune attack in MS targets the central nervous system. The lesions are well-localised and are called “plaques”.
In recent years, it has been shown that starting treatment early in MS patients significantly improves the long-term prognosis in the relapsing-remitting forms. It is therefore critically important that MS be diagnosed as soon as possible ...
Why does a person with a particular predisposition due to hereditary genetic factors develop the disease at all? Lies Van Horebeek proposes a novel explanation in her research project...
Twice a year, the Charcot Foundation publishes a Bulletin which wants to be the objective reflection of research and last acquisitions in Multiple sclerosis as well in the field of our knowledge of the disease as of the new treatments under study
